Legal Representation
Attorney
Julie A. Katz
USPTO Deadlines
Next Deadline
1811 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20250121)
Due Date
January 21, 2031
Grace Period Ends
July 21, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
33 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 29, 2025 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Aug 3, 2025 | XXSS | O | GENERIC MADRID TRANSACTION SENT TO IB | Loading... |
| Aug 3, 2025 | XXCR | P | GENERIC MADRID TRANSACTION CREATED | Loading... |
| May 3, 2025 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Apr 21, 2025 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Apr 15, 2025 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Apr 15, 2025 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Jan 21, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jan 21, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Dec 3, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 3, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 27, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 11, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 11, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Nov 11, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 11, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 11, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Oct 28, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 15, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| May 15, 2024 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| May 15, 2024 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| May 1, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 1, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 1, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 30, 2024 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Apr 9, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Apr 9, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Mar 14, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Mar 13, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 13, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 21, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Nov 17, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 16, 2023 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 001
Industrial chemicals; chemicals used in science; Nucleic acids for scientific purposes; Nucleotides for scientific and research use, namely, oligonucleotides
Class 005
Nucleic acid for medical diagnostic purposes; Oligonucleotides for medical diagnostic purposes; Oligonucleotides for pharmaceutical purposes; Pharmaceutical preparations for medical diagnostic purposes in the nature of diagnostic agents for medical use; chemical preparations for pharmaceutical purposes in the nature of diagnostic agents for medical use; Pharmaceutical preparations made of nucleic acids and nucleotides, in particular oligonucleotides, for pharmaceutical purposes
Class 040
Distilling of chemicals for others, namely, oligonucleotides; Custom manufacture of pharmaceuticals using oligonucleotides for third parties
Class 042
Scientific and technological services, and research and design in the field of nucleic acids, nucleotides and oligonucleotides; industrial analysis and industrial research of nucleic acids, nucleotides and oligonucleotides
Class 044
Analysis of nucleic acids and oligonucleotides for medical diagnostics and medical treatment
Additional Information
Design Mark
The mark consists of the stylized wording "BIOSPRING" in blue next to the stylized design of a double helix within a circle and surrounded by an incomplete circle, all in green. The white background is not claimed as a feature of the mark.
Color Claim
The color(s) blue and green is/are claimed as a feature of the mark.
Classification
International Classes
001
005
040
042
044